Last reviewed · How we verify
NCT03193229
MapTrek to Increase Activity Among Patients at Risk for Type 2 Diabetes
NA trial testing MapTrek in Pre Diabetes in 430 participants. Completed in 4 May 2018.
2 April 2018
Quick facts
| Lead sponsor | Philip Polgreen |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | prevention |
| Enrollment | 430 |
| Start date | 15 May 2017 |
| Primary completion | 2 April 2018 |
| Estimated completion | 4 May 2018 |
| Sites | 1 location across United States |
Drugs / interventions tested
- MapTrek
- Fitbit
Conditions studied
- Pre Diabetes — all drugs for Pre Diabetes →
- Obesity — all drugs for Obesity →
Sponsor
Philip Polgreen
Who can join
Adults 21 to 80, any sex, with Pre Diabetes or Obesity. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The overarching objective of our work is to provide an inexpensive and scalable m-health tool to increase both volume and intensity of physical activity and reduce sedentary behavior in patients at risk for type 2 diabetes. The objective of this study is to pilot test MapTrek, a text-messaging based intervention.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Gamifying accelerometer use increases physical activity levels of individuals pre-disposed to type II diabetes.
Francis SL, Simmering JE, Polgreen LA, Evans NJ, et al · · 2021 · cited 9× · PMID 34178586 · DOI 10.1016/j.pmedr.2021.101426
Verify or expand the search:
- PubMed search for NCT03193229
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of MapTrek
Trials testing the same drug.
- NCT04041869 — Residential MapTrek- Increasing Physical Activity Among Older Adults in a Residential-Living · NA · completed
- NCT03720054 — An M-Health Intervention in Rural Veterans · NA · completed
Other recruiting trials for Pre Diabetes
Currently open trials in the same condition.
- NCT07252700 — Preventing Diabetes: Impact of an EMR-Based Intervention for Enhanced Pre-Diabetes Management in Primary Care · NA · recruiting
- NCT06986161 — Optimizing Mango's Glycemic Impact: Investigating Mango Consumption Timing in Prediabetic Individuals · NA · recruiting
- NCT06426277 — Effectiveness of the Brazilian Diabetes Prevention Program · NA · recruiting
- NCT06387797 — Primary and Secondary Prevention of Type 2 Diabetes Mellitus in Clark County · NA · recruiting
- NCT06555952 — MegaNatural BP® GSE on Blood Pressure and Cardiometabolic Risk Factors · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT03193229 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Philip Polgreen
- Last refreshed: 16 October 2018
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03193229.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing